<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02409277</url>
  </required_header>
  <id_info>
    <org_study_id>51002874</org_study_id>
    <nct_id>NCT02409277</nct_id>
  </id_info>
  <brief_title>Redesigning Ambulatory Care Delivery to Enhance Asthma Control in Children</brief_title>
  <official_title>Redesigning Ambulatory Care Delivery to Enhance Asthma Control in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Utah</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Patient-Centered Outcomes Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Utah</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators have developed a tool to facilitate asthma self-management in children, the
      electronic-AsthmaTracker (e-AT). The e-AT changes ambulatory asthma care delivery to a new
      model that is continuous and proactive, focusing on prevention and control, rather than
      reactive and focusing on management of asthma attacks. The e-AT 1) engages parents in weekly
      monitoring of their child's chronic asthma symptoms, 2) guides parents to recognize warning
      signs of asthma attacks in order to prompt appropriate interventions and timely visits to
      Primary Care Providers, and 3) provides Primary Care Providers with real-time, objective
      patient data to assess the effectiveness of asthma therapy and prompt adjustments. In a
      preliminary study of the paper-based version of the AT, frequent users had significantly
      fewer emergency department (ED) and hospital visits. Parent comments during the e-AT pilot
      testing revealed that the tool was useful in helping them manage their child's asthma and
      were interested in assessing the tool's effectiveness and in identifying and addressing
      barriers to their sustained use of the e-AT.

      Improving asthma control in children will be facilitated by broad e-AT dissemination, and by
      identifying and addressing critical factors that contribute to parent sustained participation
      in self-management. The investigators propose to assess the effectiveness of the new
      ambulatory care model supported by the e-AT and conduct an e-AT process evaluation, assessing
      barriers and facilitators of sustained parent use. The investigators will engage parents
      throughout this study to identify and address themes that matter to them. The target
      population is children with persistent asthma, ages 2-17 years. The investigators have
      engaged 10 parents since conception of this project, from the planning to design and
      validation of the paper-AT, and the design and pilot testing of the e-AT. Input from parents
      was received through 3 iterative focus groups (one for the paper-AT and 2 for the e-AT) and
      facilitated discussions to inform the development of this proposal including research
      objectives and outcome measures. In addition, the investigators have recruited other key
      stakeholders for whom the results of the research will be relevant.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Through the following specific aims, the investigators will:

      Aim 1: Assess the effectiveness of the new ambulatory care model, by comparing outcomes at
      the 1.a. child (child's quality of life (QOL), asthma control, missed school days),
      1.b.parent (satisfaction, parent missed work days) and 1.c. clinic (ED/hospital visits)
      levels, between clinics randomly assigned to either the standard e-AT intervention vs.
      intensive e-AT intervention. 1.d. Use non randomized comparisons to determine the
      effectiveness of the e-AT relative to a control group (usual care) in which the e-AT was not
      used

      Aim 2: Assess the association of QOL, asthma control, and ED/hospital admissions with the
      prior frequency of e-AT use and assess if the association differs between parent subgroups
      (high vs. low literacy, Medicaid vs. private insurance, and frequent vs. less frequent e-AT
      users).

      Aim 3: Determine the association of demographic, socio-economic, behavioral, and technology
      factors with sustained parent participation in asthma self-management.

      The outcome measures are:

      Primary Outcome:

        1. Child quality of life (QOL)

           Secondary Outcomes:

        2. Child asthma control

        3. Child interrupted/missed school days

        4. Child use of oral steroids (surrogate measure of an asthma exacerbation)

        5. Parent satisfaction with care

        6. Parent interruption/missed work days

        7. Clinics: ED/Hospital admissions
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2013</start_date>
  <completion_date type="Actual">December 31, 2016</completion_date>
  <primary_completion_date type="Actual">December 31, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>We initially enrolled 327 randomized (at the clinic level) participants who received the e-AT interventions overall, including 267 participants receiving the standard intervention and 60 receiving the intensive intervention. We also included another set of 599 non-randomized matched controls of patients with persistent asthma retrieved electronically from non-participating clinics. This is why we stated that 926 subjects (327+599) overall were included.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Patient Quality of Life (QOL), Compared Mean QOL Change From Baseline at Each Follow-up Assessment Between the Clinics Assigned to the Intensive and Standard e-AT Interventions</measure>
    <time_frame>Quality of Life assessed at baseline, then compared to 3 months, 6 months, and 12 months after intervention.</time_frame>
    <description>Patient QOL and missed school days was collected longitudinally through surveys of the study population defined above. The QOL questionnaire included the Integrated Therapeutics Group Child Asthma Short Form (ITG-CASF) and was used at baseline (at first assessment), 3, 6, and 12 months in the study.
Items within QOL scales are summed and linearly transformed from 0 to 100, with higher scores indicating better functioning.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient Quality of Life (QOL), Overall Longitudinal Change (From Baseline) Within All Subjects (Who Received the e-AT Intervention)</measure>
    <time_frame>Average Baseline QOL was compared to QOL scores at 3, 6 and 12 month follow-up QOL</time_frame>
    <description>Patient QOL and missed school days was collected longitudinally through surveys of the study population defined above. The QOL questionnaire included the Integrated Therapeutics Group Child Asthma Short Form - ITG-CASF and was used at baseline (at first assessment), 3, 6, and 12 months in the study. Items within scales are summed and linearly transformed from 0 to 100, with higher scores indicating better functioning.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Parent Satisfaction With Care, Standard vs Intensive</measure>
    <time_frame>Changes in satisfaction was compared between 12 month follow-up and baseline satisfaction across Standard and Intensive interventions</time_frame>
    <description>Parent satisfaction data was collected at baseline and at 12 months in the study.
The scale ranges from 1-5, with 1 being &quot;Very Dissatisfied&quot; and 5 &quot;Very Satisfied&quot;.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Child Interrupted/Missed School Days, Standard vs Intensive</measure>
    <time_frame>Interrupted/missed school days were collected at baseline, 3, 6, and 12 month follow-ups</time_frame>
    <description>Number of child interrupted/missed school days were collected longitudinally at the same time as collecting the QOL scores: baseline, 3, 6, and 12 months in the study.
Number of child interrupted/missed school days during the 3 months prior to baseline, 3, 6, and 12 months follow-up surveys were counted.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parent Interrupted/Missed Work Days, Standard vs Intensive</measure>
    <time_frame>Interrupted/missed work days were measured baseline 3, 6, and 12 months</time_frame>
    <description>Number of parent interrupted/missed work days were collected longitudinally at the same time as collecting the QOL scores: baseline, 3, 6, and 12 months in the study.
Number of parent interrupted/missed work days during the 3 months prior to baseline, 3, 6, and 12 months follow-up surveys were counted.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Asthma Control Change, Standard vs Intensive</measure>
    <time_frame>Average baseline ACT scores compared to average ACT scores at quarter 1, 2, 3 and 4, and between Standard vs. Intensive</time_frame>
    <description>Asthma control information was collected weekly through the e-AT for 1 year. Asthma control was measured using the Asthma Control Test (ACT), which had a score ranging from 5 to 25, with 5 being poor control and 25 being optimal control. The analysis compared the mean change in scores from baseline to quarters 1, 2, 3, and 4.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Emergency Department (ED)/Hospitalization, Standard vs Intensive</measure>
    <time_frame>Change in 1 year ED/hospital admission between 12-month prior and 12 month post e-AT use</time_frame>
    <description>ED and hospital admissions were evaluated using data collected through Intermountain Healthcare claims data and ED visits and hospital encounters.
We evaluated number ED and hospital admissions 12 months prior to intervention and 12 months post intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parent Satisfaction With Care, Overall (Change Overtime From Baseline to 12 Months)</measure>
    <time_frame>Satisfaction at 1 year following e-AT use was compared to baseline satisfaction scores</time_frame>
    <description>Parent satisfaction data was collected using a modified version of patient satisfaction survey developed and validated by Varni et al. at baseline and at 12 months in the study.
The scale ranged from 1-5, with 1=Very Dissatisfied and 5=Very Satisfied.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Child Asthma Control Overall (Comparing Change of Asthma Control From Baseline to Quarter 1, Quarter 2, Quarter 3 and Quarter 4)</measure>
    <time_frame>baseline ACT scores were compared to quarters 1, 2, 3, 4.</time_frame>
    <description>Asthma control information was collected through the e-AT, comparing change of asthma control from baseline to quarter 1, quarter 2, quarter 3 and quarter 4.
Asthma control was measured using the Asthma Control Test (ACT), which scale ranged from 5-25, with 5=poorly controlled and 25=well controlled.
Each patient submitted an ACT score weekly for 12 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Child Interrupted/Missed School Days, Overall (Longitudinal Changes Overtime)</measure>
    <time_frame>1 year</time_frame>
    <description>Number of child interrupted/missed school days were collected longitudinally (information includes mean at baseline, 3, 6, and 12 months in the study).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parent Interrupted/Missed Work Days, Overall (Longitudinal Change Overtime)</measure>
    <time_frame>1 year</time_frame>
    <description>Number of parent interrupted/missed work days were collected longitudinally at the same time as collecting the QOL scores: Information includes mean at baseline, 3, 6, and 12 months in the study.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ED/Hospital Admissions, e-AT Overall (Pre vs. Post e-AT Use Within Subjects That Received the e-AT Intervention)</measure>
    <time_frame>1 year</time_frame>
    <description>ED/hospital re-admission data were compared between prior and post 12 month period (for both intensive and standard interventions overall) when e-AT was administered.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of Oral Steroid, Overall</measure>
    <time_frame>1 year</time_frame>
    <description>Use of oral steroid was evaluated using data collected through Intermountain Healthcare claims data and oral steroids prescribed. Comparison was made between prior and post e-AT (both interventions) overall.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ED/Hospital Admission, Early vs. Late Patients</measure>
    <time_frame>1 year following e-AT use for early and late starting patients</time_frame>
    <description>ED and hospital admission was evaluated using data collected through Intermountain Healthcare claims data and ED visits and hospital encounters. Analyses (at the patient level) comparing the rates of ED/hospital admissions between a 1 year period following initiation of the e-AT for those in both standard and intensive e-AT groups who were enrolled early during the study period (patients with enrollment dates between January 2014 and December 2014) to rates of ED/hospital admissions for patients who started the e-AT later (patients with enrollment dates between January 2015 and December 2015), during a 1-year period prior to the late patient starting the e-AT.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oral Steroid Use, Early vs. Late Patients</measure>
    <time_frame>1 year</time_frame>
    <description>Oral steroid use data was collected through Intermountain Healthcare claims data and clinics prescribing oral steroid.
Oral steroid use was evaluated using data collected through Intermountain Healthcare claims data and oral steroids prescribed. Analyses (at the patient level) comparing the rates oral steroid use between a 1 year period following initiation of the e-AT for those in both standard and intensive e-AT groups who were enrolled early during the study period (patients with enrollment dates between January 2014 and December 2014) to rates of oral steroid use for patients who started the e-AT later (patients with enrollment dates between January 2015 and December 2015), during a 1-year period prior to the late patient starting the e-AT.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ED/Hospital Admission, Early vs Late Starting Clinics (During the 3 Months When Late Starting Clinics Have Not Used the e-AT)</measure>
    <time_frame>3-month period prior to the late clinics starting the e-AT</time_frame>
    <description>ED and hospital admission evaluated using data collected through Intermountain Healthcare claims data and ED visits and hospital encounters. Statistical analysis was not conducted since the numbers of ED/Hospital admissions was very small (2 and 0) in both group (during the 3 months study window). Here we used intent-to-treat analysis and included the overall 325 (rather than 318 used in analysis of other outcomes) participants.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oral Steroid Use, Early vs Late Starting Clinics (During the 3 Months When Late Starting Clinics Have Not Started the e-AT)</measure>
    <time_frame>3 month period prior to the late clinics starting the e-AT</time_frame>
    <description>Use of oral steroid was evaluated using data collected through Intermountain Healthcare claims data and oral steroids prescribed. Statistical analysis was not conducted since the numbers of ED/Hospital admissions was very small (2 and 0) in both group (during the 3 months study window). Here we used intent-to-treat analysis and included the overall 325 (rather than 318 used in analysis of other outcomes) participants</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ED/Hospital Admissions, e-AT vs Usual Care</measure>
    <time_frame>1 year</time_frame>
    <description>Non randomized comparison of ED and hospital admissions between e-AT interventions (both intensive and standard) compared usual care (matched control patients drawn from non-participating clinics) in the prior vs. post e-AT intervention time periods.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oral Steroid Use, e-AT vs Usual Care</measure>
    <time_frame>1 year</time_frame>
    <description>Non randomized comparison of use of oral steroid between e-AT interventions (both intensive and standard) compared usual care (matched control patients drawn from non-participating clinics) in the prior vs. post e-AT intervention time periods.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">926</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Standard e-AT Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in Standard e-AT or standard intervention group will receive a daily (if a participant forgets to complete his/her weekly assessment) email and text reminders with a link to the e-AT website to help patient/parent participants to comply with their weekly assessment of patient's level of asthma control. Note: patient/parent participants are required to complete their asthma control assessment 1x/week. The e-AT is now set up to send a weekly reminder to participants with a link to the website. If a participant does not complete an assessment within a week of the last assessment, the reminder will be sent daily until the patient/parent complies and the system resets to weekly.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intensive e-AT Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in the intensive e-AT or adherence support intervention will receive everything as those in Standard Intervention. In addition, they will see a progress bar display, which adds 25 points each time they complete an assessment. When this bar reaches 100 points, a pop-up message with fireworks will appear to congratulate them about the milestone. The progress bar resets to zero after it reaches 100 points. Participants will also see a leader board allowing them to compare themselves with the 5 best users to increase compliance.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care (Non-Randomized Cohort)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Both arms (Intensive and standard e-AT interventions) will be compared to each other as well as to a non-randomized cohort who did not receive the e-AT interventions. These non-randomized cohort will be matched 2:1 to each randomized individuals.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Experimental: Standard vs Intensive e-AT Intervention</intervention_name>
    <description>Patients will be self-monitoring their symptoms weekly using the e-AT, either the Standard or Intensive versions of the e-AT, completing the Asthma Control Test. As patients complete their assessments each week, the clinics will be able to see how each patient is doing, and follow-up when a patient is showing high symptoms for that week, potentially avoiding Emergency Room visit, and/or hospitalization.</description>
    <arm_group_label>Intensive e-AT Intervention</arm_group_label>
    <arm_group_label>Standard e-AT Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Facility Eligibility

        Clinics are eligible for participation if they meet the following criteria:

          1. Primary care clinics with the clinical leadership to adopt use of e-AT for asthma
             management.

          2. Have patients between 2 and 17 years of age with persistent asthma.

          3. Ability of the facility to accommodate patient enrollment and training about use of
             e-AT.

        Patient Inclusion Criteria

          1. Children ages 2 through 17 years and their parents (main parents or caregiver)

          2. English speakers

          3. Children who received or are receiving asthma treatment (at participating clinics).

          4. Parents have Internet access

          5. Children with persistent asthma.

        Patient Exclusion Criteria:

        As this is a pragmatic trial assessing evidence of the e-AT in a real clinical environment,
        no patients will be excluded as long as they meet inclusion criteria. However, during the
        time of analysis, we will conduct a sub-analysis, comparing the effectiveness of the new
        care model among patients with or without co-morbid conditions that may affect measured
        asthma outcomes. These include patients with a history or increased risk of pulmonary
        disease (cystic fibrosis, bronco-pulmonary dysplasia, aspiration pneumonia, severe Cerebral
        Palsy (CP) with aspiration risk, technology dependency (gastrostomy tube, tracheostomy),
        history of congenital heart disease requiring surgical correction or with complicating
        congestive heart failure requiring medical management, immunodeficiency (including patients
        on immunosuppressants), and malignancies.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Flory Nkoy, MD, MS, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Utah</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84113</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>CDC. National Health Interview Survey (NHIS) Data2009. http://www.cdc.gov/asthma/nhis/09/data.htm</citation>
  </reference>
  <reference>
    <citation>Akinbami LJ, Moorman JE, Liu X. Asthma prevalence, health care use, and mortality: United States, 2005-2009. Natl Health Stat Report. 2011 Jan 12;(32):1-14.</citation>
    <PMID>21355352</PMID>
  </reference>
  <reference>
    <citation>CDC. Healthy Youth! Health Topics, Asthma2009.</citation>
  </reference>
  <reference>
    <citation>Wessel L, Spain J. The Chronic Care Model: A Collaborative Approach to Preventing and Treating Asthma in Infants and Young Children. January 2005. EJ847179</citation>
  </reference>
  <reference>
    <citation>Association AL. Asthma &amp; Children Fact Sheet 2012. http://www.lung.org/lung-disease/asthma/resources/facts-and-figures/asthma-children-fact-sheet.html</citation>
  </reference>
  <reference>
    <citation>Farber HJ. Risk of readmission to hospital for pediatric asthma. J Asthma. 1998;35(1):95-9.</citation>
    <PMID>9513588</PMID>
  </reference>
  <reference>
    <citation>Minkovitz CS, Andrews JS, Serwint JR. Rehospitalization of children with asthma. Arch Pediatr Adolesc Med. 1999 Jul;153(7):727-30.</citation>
    <PMID>10401806</PMID>
  </reference>
  <reference>
    <citation>Lieu TA, Quesenberry CP, Sorel ME, Mendoza GR, Leong AB. Computer-based models to identify high-risk children with asthma. Am J Respir Crit Care Med. 1998 Apr;157(4 Pt 1):1173-80.</citation>
    <PMID>9563736</PMID>
  </reference>
  <reference>
    <citation>Rea HH, Scragg R, Jackson R, Beaglehole R, Fenwick J, Sutherland DC. A case-control study of deaths from asthma. Thorax. 1986 Nov;41(11):833-9.</citation>
    <PMID>3824270</PMID>
  </reference>
  <reference>
    <citation>Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. N Engl J Med. 1992 Mar 26;326(13):862-6.</citation>
    <PMID>1542323</PMID>
  </reference>
  <reference>
    <citation>Smith DH, Malone DC, Lawson KA, Okamoto LJ, Battista C, Saunders WB. A national estimate of the economic costs of asthma. Am J Respir Crit Care Med. 1997 Sep;156(3 Pt 1):787-93.</citation>
    <PMID>9309994</PMID>
  </reference>
  <reference>
    <citation>Bloomberg GR, Trinkaus KM, Fisher EB Jr, Musick JR, Strunk RC. Hospital readmissions for childhood asthma: a 10-year metropolitan study. Am J Respir Crit Care Med. 2003 Apr 15;167(8):1068-76.</citation>
    <PMID>12684246</PMID>
  </reference>
  <reference>
    <citation>Crane J, Pearce N, Burgess C, Woodman K, Robson B, Beasley R. Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. Int J Epidemiol. 1992 Aug;21(4):737-44.</citation>
    <PMID>1521979</PMID>
  </reference>
  <reference>
    <citation>Li D, German D, Lulla S, Thomas RG, Wilson SR. Prospective study of hospitalization for asthma. A preliminary risk factor model. Am J Respir Crit Care Med. 1995 Mar;151(3 Pt 1):647-55.</citation>
    <PMID>7881651</PMID>
  </reference>
  <reference>
    <citation>To T, Dick P, Feldman W, Hernandez R. A cohort study on childhood asthma admissions and readmissions. Pediatrics. 1996 Aug;98(2 Pt 1):191-5.</citation>
    <PMID>8692616</PMID>
  </reference>
  <reference>
    <citation>Chapman KR, Boulet LP, Rea RM, Franssen E. Suboptimal asthma control: prevalence, detection and consequences in general practice. Eur Respir J. 2008 Feb;31(2):320-5. Epub 2007 Oct 24.</citation>
    <PMID>17959642</PMID>
  </reference>
  <reference>
    <citation>Centers for Disease Control and Prevention (CDC). Asthma hospitalizations and readmissions among children and young adults--Wisconsin, 1991-1995. MMWR Morb Mortal Wkly Rep. 1997 Aug 8;46(31):726-9.</citation>
    <PMID>9262074</PMID>
  </reference>
  <reference>
    <citation>Mitchell EA, Bland JM, Thompson JM. Risk factors for readmission to hospital for asthma in childhood. Thorax. 1994 Jan;49(1):33-6.</citation>
    <PMID>8153938</PMID>
  </reference>
  <reference>
    <citation>Vargas PA, Perry TT, Robles E, Jo CH, Simpson PM, Magee JM, Feild CR, Hakkak R, Carroll PA, Jones SM. Relationship of body mass index with asthma indicators in head start children. Ann Allergy Asthma Immunol. 2007 Jul;99(1):22-8.</citation>
    <PMID>17650825</PMID>
  </reference>
  <reference>
    <citation>Barnes PJ. Achieving asthma control. Curr Med Res Opin. 2005;21 Suppl 4:S5-9. Review.</citation>
    <PMID>16138939</PMID>
  </reference>
  <reference>
    <citation>Bloomberg GR, Banister C, Sterkel R, Epstein J, Bruns J, Swerczek L, Wells S, Yan Y, Garbutt JM. Socioeconomic, family, and pediatric practice factors that affect level of asthma control. Pediatrics. 2009 Mar;123(3):829-35. doi: 10.1542/peds.2008-0504.</citation>
    <PMID>19255010</PMID>
  </reference>
  <reference>
    <citation>Bateman ED, Frith LF, Braunstein GL. Achieving guideline-based asthma control: does the patient benefit? Eur Respir J. 2002 Sep;20(3):588-95.</citation>
    <PMID>12358333</PMID>
  </reference>
  <reference>
    <citation>Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, Weiss KB, Weiss ST. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol. 2004 Jul;114(1):40-7.</citation>
    <PMID>15241342</PMID>
  </reference>
  <reference>
    <citation>National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol. 2007 Nov;120(5 Suppl):S94-138. Erratum in: J Allergy Clin Immunol. 2008 Jun;121(6):1330.</citation>
    <PMID>17983880</PMID>
  </reference>
  <reference>
    <citation>Stempel DA, McLaughin TP, Stanford RH, Fuhlbrigge AL. Patterns of asthma control: a 3-year analysis of patient claims. J Allergy Clin Immunol. 2005 May;115(5):935-9.</citation>
    <PMID>15867848</PMID>
  </reference>
  <reference>
    <citation>Williams SG, Schmidt DK, Redd SC, Storms W; National Asthma Education and Prevention Program. Key clinical activities for quality asthma care. Recommendations of the National Asthma Education and Prevention Program. MMWR Recomm Rep. 2003 Mar 28;52(RR-6):1-8.</citation>
    <PMID>12696781</PMID>
  </reference>
  <reference>
    <citation>New NHLBI guidelines for the diagnosis and management of asthma. National Heart, Lung and Blood Institute. Lippincott Health Promot Lett. 1997 Aug;2(7):1, 8-9.</citation>
    <PMID>9300898</PMID>
  </reference>
  <reference>
    <citation>Glauber JH, Farber HJ, Homer CJ. Asthma clinical pathways: toward what end? Pediatrics. 2001 Mar;107(3):590-2.</citation>
    <PMID>11230605</PMID>
  </reference>
  <reference>
    <citation>Ressel GW; Centers for Disease Control and Prevention; National Asthma Education and Prevention Program. NAEPP updates guidelines for the diagnosis and management of asthma. Am Fam Physician. 2003 Jul 1;68(1):169-70.</citation>
    <PMID>12887123</PMID>
  </reference>
  <reference>
    <citation>Jovicic A, Holroyd-Leduc JM, Straus SE. Effects of self-management intervention on health outcomes of patients with heart failure: a systematic review of randomized controlled trials. BMC Cardiovasc Disord. 2006 Nov 2;6:43. Review.</citation>
    <PMID>17081306</PMID>
  </reference>
  <reference>
    <citation>Clark DO, Frankel RM, Morgan DL, Ricketts G, Bair MJ, Nyland KA, Callahan CM. The meaning and significance of self-management among socioeconomically vulnerable older adults. J Gerontol B Psychol Sci Soc Sci. 2008 Sep;63(5):S312-9.</citation>
    <PMID>18818452</PMID>
  </reference>
  <reference>
    <citation>McGowan P. Self-Managment: A Background Paper. Centre on Aging New Perspectives: International Conference on Patient Self-Management 2006:1-10.</citation>
  </reference>
  <reference>
    <citation>Barlow J, Wright C, Sheasby J, Turner A, Hainsworth J. Self-management approaches for people with chronic conditions: a review. Patient Educ Couns. 2002 Oct -Nov;48(2):177-87. Review.</citation>
    <PMID>12401421</PMID>
  </reference>
  <reference>
    <citation>Adams WG, Fuhlbrigge AL, Miller CW, Panek CG, Gi Y, Loane KC, Madden NE, Plunkett AM, Friedman RH. TLC-Asthma: an integrated information system for patient-centered monitoring, case management, and point-of-care decision support. AMIA Annu Symp Proc. 2003:1-5.</citation>
    <PMID>14728122</PMID>
  </reference>
  <reference>
    <citation>Cruz-Correia R, Fonseca J, Lima L, Ara√∫jo L, Delgado L, Castel-Branco MG, Costa-Pereira A. Web-based or paper-based self-management tools for asthma--patients' opinions and quality of data in a randomized crossover study. Stud Health Technol Inform. 2007;127:178-89.</citation>
    <PMID>17901611</PMID>
  </reference>
  <reference>
    <citation>Finkelstein J, Cabrera MR, Hripcsak G. Internet-based home asthma telemonitoring: can patients handle the technology? Chest. 2000 Jan;117(1):148-55.</citation>
    <PMID>10631213</PMID>
  </reference>
  <reference>
    <citation>Janson SL, McGrath KW, Covington JK, Cheng SC, Boushey HA. Individualized asthma self-management improves medication adherence and markers of asthma control. J Allergy Clin Immunol. 2009 Apr;123(4):840-6. doi: 10.1016/j.jaci.2009.01.053.</citation>
    <PMID>19348923</PMID>
  </reference>
  <reference>
    <citation>Joshi A, Amelung P, Arora M, Finkelstein J. Clinical impact of home automated telemanagement in asthma. AMIA Annu Symp Proc. 2005:1000.</citation>
    <PMID>16779287</PMID>
  </reference>
  <reference>
    <citation>Ostojic V, Cvoriscec B, Ostojic SB, Reznikoff D, Stipic-Markovic A, Tudjman Z. Improving asthma control through telemedicine: a study of short-message service. Telemed J E Health. 2005 Feb;11(1):28-35.</citation>
    <PMID>15785218</PMID>
  </reference>
  <reference>
    <citation>van der Meer V, van Stel HF, Bakker MJ, Roldaan AC, Assendelft WJ, Sterk PJ, Rabe KF, Sont JK; SMASHING (Self-Management of Asthma Supported by Hospitals, ICT, Nurses and General practitioners) Study Group. Weekly self-monitoring and treatment adjustment benefit patients with partly controlled and uncontrolled asthma: an analysis of the SMASHING study. Respir Res. 2010 Jun 10;11:74. doi: 10.1186/1465-9921-11-74.</citation>
    <PMID>20537124</PMID>
  </reference>
  <reference>
    <citation>Ahmad E, Grimes DE. The effects of self-management education for school-age children on asthma morbidity: a systematic review. J Sch Nurs. 2011 Aug;27(4):282-92. doi: 10.1177/1059840511403003. Epub 2011 Apr 8. Review.</citation>
    <PMID>21478414</PMID>
  </reference>
  <reference>
    <citation>Bonner S, Zimmerman BJ, Evans D, Irigoyen M, Resnick D, Mellins RB. An individualized intervention to improve asthma management among urban Latino and African-American families. J Asthma. 2002 Apr;39(2):167-79.</citation>
    <PMID>11990232</PMID>
  </reference>
  <reference>
    <citation>Perneger TV, Sudre P, Muntner P, Uldry C, Courteheuse C, Naef AF, Jacquemet S, Nicod L, Rochat T, Assal JP. Effect of patient education on self-management skills and health status in patients with asthma: a randomized trial. Am J Med. 2002 Jul;113(1):7-14.</citation>
    <PMID>12106617</PMID>
  </reference>
  <reference>
    <citation>Rhee H, Belyea MJ, Hunt JF, Brasch J. Effects of a peer-led asthma self-management program for adolescents. Arch Pediatr Adolesc Med. 2011 Jun;165(6):513-9. doi: 10.1001/archpediatrics.2011.79.</citation>
    <PMID>21646583</PMID>
  </reference>
  <reference>
    <citation>Guendelman S, Meade K, Benson M, Chen YQ, Samuels S. Improving asthma outcomes and self-management behaviors of inner-city children: a randomized trial of the Health Buddy interactive device and an asthma diary. Arch Pediatr Adolesc Med. 2002 Feb;156(2):114-20.</citation>
    <PMID>11814370</PMID>
  </reference>
  <reference>
    <citation>Bheekie A, Syce JA, Weinberg EG. Peak expiratory flow rate and symptom self-monitoring of asthma initiated from community pharmacies. J Clin Pharm Ther. 2001 Aug;26(4):287-96.</citation>
    <PMID>11493372</PMID>
  </reference>
  <reference>
    <citation>Thompson R, Delfino RJ, Tjoa T, Nussbaum E, Cooper D. Evaluation of daily home spirometry for school children with asthma: new insights. Pediatr Pulmonol. 2006 Sep;41(9):819-28.</citation>
    <PMID>16847876</PMID>
  </reference>
  <reference>
    <citation>Chan DS, Callahan CW, Hatch-Pigott VB, Lawless A, Proffitt HL, Manning NE, Schweikert M, Malone FJ. Internet-based home monitoring and education of children with asthma is comparable to ideal office-based care: results of a 1-year asthma in-home monitoring trial. Pediatrics. 2007 Mar;119(3):569-78.</citation>
    <PMID>17332210</PMID>
  </reference>
  <reference>
    <citation>de Jongste JC, Carraro S, Hop WC; CHARISM Study Group, Baraldi E. Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma. Am J Respir Crit Care Med. 2009 Jan 15;179(2):93-7. doi: 10.1164/rccm.200807-1010OC. Epub 2008 Oct 17.</citation>
    <PMID>18931330</PMID>
  </reference>
  <reference>
    <citation>McPherson AC, Glazebrook C, Forster D, James C, Smyth A. A randomized, controlled trial of an interactive educational computer package for children with asthma. Pediatrics. 2006 Apr;117(4):1046-54.</citation>
    <PMID>16585298</PMID>
  </reference>
  <reference>
    <citation>Willems DC, Joore MA, Hendriks JJ, Nieman FH, Severens JL, Wouters EF. The effectiveness of nurse-led telemonitoring of asthma: results of a randomized controlled trial. J Eval Clin Pract. 2008 Aug;14(4):600-9. doi: 10.1111/j.1365-2753.2007.00936.x. Epub 2008 Jul 9.</citation>
    <PMID>19126178</PMID>
  </reference>
  <reference>
    <citation>Jan RL, Wang JY, Huang MC, Tseng SM, Su HJ, Liu LF. An internet-based interactive telemonitoring system for improving childhood asthma outcomes in Taiwan. Telemed J E Health. 2007 Jun;13(3):257-68.</citation>
    <PMID>17603828</PMID>
  </reference>
  <reference>
    <citation>Joseph CL, Peterson E, Havstad S, Johnson CC, Hoerauf S, Stringer S, Gibson-Scipio W, Ownby DR, Elston-Lafata J, Pallonen U, Strecher V; Asthma in Adolescents Research Team. A web-based, tailored asthma management program for urban African-American high school students. Am J Respir Crit Care Med. 2007 May 1;175(9):888-95. Epub 2007 Feb 8.</citation>
    <PMID>17290041</PMID>
  </reference>
  <reference>
    <citation>NHLBI. So You Have Asthma. 2007(NIH Publication No. 07-5248). https://www.nhlbi.nih.gov/files/docs/public/lung/have_asthma.pdf.</citation>
  </reference>
  <reference>
    <citation>Cuijpers CE, Wesseling GJ, Swaen GM, Sturmans F, Wouters EF. Asthma-related symptoms and lung function in primary school children. J Asthma. 1994;31(4):301-12.</citation>
    <PMID>8040154</PMID>
  </reference>
  <reference>
    <citation>Davis KJ, Disantostefano R, Peden DB. Is Johnny wheezing? Parent-child agreement in the Childhood Asthma in America survey. Pediatr Allergy Immunol. 2011 Feb;22(1 Pt 1):31-5. doi: 10.1111/j.1399-3038.2010.01016.x. Epub 2010 Sep 9.</citation>
    <PMID>21261742</PMID>
  </reference>
  <reference>
    <citation>Halterman JS, Yoos HL, Kitzman H, Anson E, Sidora-Arcoleo K, McMullen A. Symptom reporting in childhood asthma: a comparison of assessment methods. Arch Dis Child. 2006 Sep;91(9):766-70. Epub 2006 May 16.</citation>
    <PMID>16705016</PMID>
  </reference>
  <reference>
    <citation>McQuaid EL, Koinis Mitchell D, Walders N, Nassau JH, Kopel SJ, Klein RB, Wamboldt MZ, Fritz GK. Pediatric asthma morbidity: the importance of symptom perception and family response to symptoms. J Pediatr Psychol. 2007 Mar;32(2):167-77. Epub 2006 May 22.</citation>
    <PMID>16717140</PMID>
  </reference>
  <reference>
    <citation>Hagmolen Of Ten Have W, van den Berg NJ, van der Palen J, van Aalderen WM, Bindels PJ. Limitations of questioning asthma to assess asthma control in general practice. Respir Med. 2008 Aug;102(8):1153-8. doi: 10.1016/j.rmed.2008.03.008. Epub 2008 Jun 24.</citation>
    <PMID>18573649</PMID>
  </reference>
  <reference>
    <citation>Bridge PD, McKenzie SA. Bronchodilator responsiveness testing in young children. Arch Dis Child. 2001 Jun;84(6):525.</citation>
    <PMID>11372088</PMID>
  </reference>
  <reference>
    <citation>NHLBI-EPR-3. Guidelines for the diagnosis ane management of asthma. Periodic Assessment and Monitoring: Essential for Asthma Management. 2007. http://www.nhlbi.nih.gov/files/docs/guidelines/asthsumm.pdf</citation>
  </reference>
  <reference>
    <citation>Tirimanna PR, Den Otter JJ, Van Schayck CP, Van Herwaarden CL, Folgering H, Van Weel C. Evaluation of the suitability of weekly peak expiratory flow rate measurements in monitoring annual decline in lung function among patients with asthma and chronic bronchitis. Br J Gen Pract. 1996 Jan;46(402):15-8.</citation>
    <PMID>8745846</PMID>
  </reference>
  <reference>
    <citation>Frischer T, Meinert R, Urbanek R, Kuehr J. Variability of peak expiratory flow rate in children: short and long term reproducibility. Thorax. 1995 Jan;50(1):35-9.</citation>
    <PMID>7886646</PMID>
  </reference>
  <reference>
    <citation>Goldberg S, Springer C, Avital A, Godfrey S, Bar-Yishay E. Can peak expiratory flow measurements estimate small airway function in asthmatic children? Chest. 2001 Aug;120(2):482-8.</citation>
    <PMID>11502647</PMID>
  </reference>
  <reference>
    <citation>Liu AH, Zeiger R, Sorkness C, Mahr T, Ostrom N, Burgess S, Rosenzweig JC, Manjunath R. Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol. 2007 Apr;119(4):817-25. Epub 2007 Mar 13.</citation>
    <PMID>17353040</PMID>
  </reference>
  <reference>
    <citation>Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004 Jan;113(1):59-65.</citation>
    <PMID>14713908</PMID>
  </reference>
  <reference>
    <citation>McGrath AM, Gardner DM, McCormack J. Is home peak expiratory flow monitoring effective for controlling asthma symptoms? J Clin Pharm Ther. 2001 Oct;26(5):311-7. Review.</citation>
    <PMID>11679021</PMID>
  </reference>
  <reference>
    <citation>Juniper EF, Gruffydd-Jones K, Ward S, Svensson K. Asthma Control Questionnaire in children: validation, measurement properties, interpretation. Eur Respir J. 2010 Dec;36(6):1410-6. doi: 10.1183/09031936.00117509. Epub 2010 Jun 7.</citation>
    <PMID>20530041</PMID>
  </reference>
  <reference>
    <citation>Kattan M. Quality of inpatient care for asthma: challenges and opportunities. Pediatrics. 2008 Dec;122(6):1369-70. doi: 10.1542/peds.2008-2787.</citation>
    <PMID>19047258</PMID>
  </reference>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>March 25, 2015</study_first_submitted>
  <study_first_submitted_qc>March 31, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 6, 2015</study_first_posted>
  <results_first_submitted>July 7, 2017</results_first_submitted>
  <results_first_submitted_qc>January 24, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">February 5, 2020</results_first_posted>
  <last_update_submitted>January 24, 2020</last_update_submitted>
  <last_update_submitted_qc>January 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Utah</investigator_affiliation>
    <investigator_full_name>Flory Nkoy</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Self-Management</keyword>
  <keyword>Asthma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>We can only share completely de-identified data. Request can be sent to my email: flory.nkoy@hsc.utah.edu</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Standard e-Asthma Tracker (e-AT) Intervention</title>
          <description>Patients in Standard e-AT intervention group will be using the standard version of e-AT</description>
        </group>
        <group group_id="P2">
          <title>Intensive e-Asthma Tracker (e-AT) Intervention</title>
          <description>Participants in the intensive e-AT intervention group will be using an enhanced version of the standard e-AT, i.e. addition of progress bar indicating the patients' status of completing 4 scores in a month, fireworks when they reach 100% on the progress bar, a leaderboard to compare their own status among other e-AT users.</description>
        </group>
        <group group_id="P3">
          <title>Usual Care (Non-Randomized Cohort)</title>
          <description>Both arms (Intensive and standard e-AT interventions) will be compared to each other as well as to a non-randomized cohort who did not receive the e-AT interventions. These non-randomized cohort will be matched 2:1 to each randomized individuals.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="267"/>
                <participants group_id="P2" count="60"/>
                <participants group_id="P3" count="599"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>3 Months Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="178"/>
                <participants group_id="P2" count="40"/>
                <participants group_id="P3" count="599"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>6 Months Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="182"/>
                <participants group_id="P2" count="42"/>
                <participants group_id="P3" count="599"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>12 Months Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="167"/>
                <participants group_id="P2" count="43"/>
                <participants group_id="P3" count="599"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="167"/>
                <participants group_id="P2" count="43"/>
                <participants group_id="P3" count="599"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="100"/>
                <participants group_id="P2" count="17"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Standard e-AT Intervention</title>
          <description>Patients in Standard e-AT intervention group will be using the standard version of e-AT.</description>
        </group>
        <group group_id="B2">
          <title>Intensive e-AT Intervention</title>
          <description>Participants in the intensive e-AT intervention group will be using an enhanced version of the standard e-AT, i.e. addition of progress bar indicating the patients' status of completing 4 scores in a month, fireworks when they reach 100% on the progress bar, a leaderboard to compare their own status among other e-AT users.</description>
        </group>
        <group group_id="B3">
          <title>Usual Care (Non-Randomized Cohort)</title>
          <description>Both arms (Intensive and standard e-AT interventions) will be compared to each other as well as to a non-randomized cohort who did not receive the e-AT interventions. These non-randomized cohort will be matched 2:1 to each randomized individuals.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="267"/>
            <count group_id="B2" value="60"/>
            <count group_id="B3" value="599"/>
            <count group_id="B4" value="926"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="267"/>
                    <measurement group_id="B2" value="60"/>
                    <measurement group_id="B3" value="599"/>
                    <measurement group_id="B4" value="926"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8.12" spread="3.99"/>
                    <measurement group_id="B2" value="7.18" spread="8.12"/>
                    <measurement group_id="B3" value="8.04" spread="3.86"/>
                    <measurement group_id="B4" value="7.97" spread="3.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="110"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="228"/>
                    <measurement group_id="B4" value="361"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="157"/>
                    <measurement group_id="B2" value="37"/>
                    <measurement group_id="B3" value="371"/>
                    <measurement group_id="B4" value="565"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="72"/>
                    <measurement group_id="B4" value="116"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="216"/>
                    <measurement group_id="B2" value="53"/>
                    <measurement group_id="B3" value="520"/>
                    <measurement group_id="B4" value="789"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="23"/>
                    <measurement group_id="B4" value="33"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="223"/>
                    <measurement group_id="B2" value="51"/>
                    <measurement group_id="B3" value="537"/>
                    <measurement group_id="B4" value="811"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="14"/>
                    <measurement group_id="B4" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="267"/>
                    <measurement group_id="B2" value="60"/>
                    <measurement group_id="B3" value="599"/>
                    <measurement group_id="B4" value="926"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Patient Quality of Life (QOL), Compared Mean QOL Change From Baseline at Each Follow-up Assessment Between the Clinics Assigned to the Intensive and Standard e-AT Interventions</title>
        <description>Patient QOL and missed school days was collected longitudinally through surveys of the study population defined above. The QOL questionnaire included the Integrated Therapeutics Group Child Asthma Short Form (ITG-CASF) and was used at baseline (at first assessment), 3, 6, and 12 months in the study.
Items within QOL scales are summed and linearly transformed from 0 to 100, with higher scores indicating better functioning.</description>
        <time_frame>Quality of Life assessed at baseline, then compared to 3 months, 6 months, and 12 months after intervention.</time_frame>
        <population>We enrolled 327, 2 clinics with only 1 patient enrolled were excluded, leaving 325 patients. Of 325, 7 did not provide baselines and were excluded, leaving 318 (261 standard vs. 57 intensive) participants. Row numbers differ due to different number of participants completing 3, 6, and 12 months follow-ups, due to withdrawal and loss to follow-up.</population>
        <group_list>
          <group group_id="O1">
            <title>Standard e-AT Intervention</title>
            <description>Patients in Standard e-AT intervention group using the standard version of e-AT.</description>
          </group>
          <group group_id="O2">
            <title>Intensive e-AT Intervention</title>
            <description>Participants in the intensive e-AT intervention group using an enhanced version of the standard e-AT, i.e. addition of progress bar indicating the patients' status of completing 4 scores in a month, fireworks when they reach 100% on the progress bar, a leaderboard to compare their own status among other e-AT users.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Quality of Life (QOL), Compared Mean QOL Change From Baseline at Each Follow-up Assessment Between the Clinics Assigned to the Intensive and Standard e-AT Interventions</title>
          <description>Patient QOL and missed school days was collected longitudinally through surveys of the study population defined above. The QOL questionnaire included the Integrated Therapeutics Group Child Asthma Short Form (ITG-CASF) and was used at baseline (at first assessment), 3, 6, and 12 months in the study.
Items within QOL scales are summed and linearly transformed from 0 to 100, with higher scores indicating better functioning.</description>
          <population>We enrolled 327, 2 clinics with only 1 patient enrolled were excluded, leaving 325 patients. Of 325, 7 did not provide baselines and were excluded, leaving 318 (261 standard vs. 57 intensive) participants. Row numbers differ due to different number of participants completing 3, 6, and 12 months follow-ups, due to withdrawal and loss to follow-up.</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="261"/>
                <count group_id="O2" value="57"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>3 Months Follow-up vs Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="178"/>
                    <count group_id="O2" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.55" spread="0.97"/>
                    <measurement group_id="O2" value="7.64" spread="2.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 Months Follow-up compared vs Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="182"/>
                    <count group_id="O2" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.37" spread="0.86"/>
                    <measurement group_id="O2" value="5.78" spread="1.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 Months Follow-up vs Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="167"/>
                    <count group_id="O2" value="43"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.39" spread="0.76"/>
                    <measurement group_id="O2" value="9.29" spread="1.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Patient Quality of Life (QOL), Overall Longitudinal Change (From Baseline) Within All Subjects (Who Received the e-AT Intervention)</title>
        <description>Patient QOL and missed school days was collected longitudinally through surveys of the study population defined above. The QOL questionnaire included the Integrated Therapeutics Group Child Asthma Short Form - ITG-CASF and was used at baseline (at first assessment), 3, 6, and 12 months in the study. Items within scales are summed and linearly transformed from 0 to 100, with higher scores indicating better functioning.</description>
        <time_frame>Average Baseline QOL was compared to QOL scores at 3, 6 and 12 month follow-up QOL</time_frame>
        <population>The numbers analyzed in the rows are different due to different number of participants completing the surveys throughout 3, 6, and 12 months. This was due to withdrawal from the study or loss to follow-up.</population>
        <group_list>
          <group group_id="O1">
            <title>All e-AT Users</title>
            <description>This group consists of all e-AT users, both standard and intensive interventions.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Quality of Life (QOL), Overall Longitudinal Change (From Baseline) Within All Subjects (Who Received the e-AT Intervention)</title>
          <description>Patient QOL and missed school days was collected longitudinally through surveys of the study population defined above. The QOL questionnaire included the Integrated Therapeutics Group Child Asthma Short Form - ITG-CASF and was used at baseline (at first assessment), 3, 6, and 12 months in the study. Items within scales are summed and linearly transformed from 0 to 100, with higher scores indicating better functioning.</description>
          <population>The numbers analyzed in the rows are different due to different number of participants completing the surveys throughout 3, 6, and 12 months. This was due to withdrawal from the study or loss to follow-up.</population>
          <units>units (points) on a scale, range 0-100</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="318"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="318"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.07" spread="14.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.98" spread="9.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="224"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.04" spread="11.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 Months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="210"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.64" spread="10.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Parent Satisfaction With Care, Standard vs Intensive</title>
        <description>Parent satisfaction data was collected at baseline and at 12 months in the study.
The scale ranges from 1-5, with 1 being &quot;Very Dissatisfied&quot; and 5 &quot;Very Satisfied&quot;.</description>
        <time_frame>Changes in satisfaction was compared between 12 month follow-up and baseline satisfaction across Standard and Intensive interventions</time_frame>
        <population>We had 261 in Standard e-AT and 57 in Intensive e-AT who completed baseline survey, and 166 in Standard e-AT and 42 in Intensive e-AT completed the 12 Months Follow-up Survey. This is due to participant withdrawal and loss to follow-up.</population>
        <group_list>
          <group group_id="O1">
            <title>Standard e-AT Intervention</title>
            <description>Patients in Standard e-AT intervention group will be using the standard version of e-AT.</description>
          </group>
          <group group_id="O2">
            <title>Intensive e-AT Intervention</title>
            <description>Participants in the intensive e-AT intervention group will be using an enhanced version of the standard e-AT, i.e. addition of progress bar indicating the patients' status of completing 4 scores in a month, fireworks when they reach 100% on the progress bar, a leaderboard to compare their own status among other e-AT users.</description>
          </group>
        </group_list>
        <measure>
          <title>Parent Satisfaction With Care, Standard vs Intensive</title>
          <description>Parent satisfaction data was collected at baseline and at 12 months in the study.
The scale ranges from 1-5, with 1 being &quot;Very Dissatisfied&quot; and 5 &quot;Very Satisfied&quot;.</description>
          <population>We had 261 in Standard e-AT and 57 in Intensive e-AT who completed baseline survey, and 166 in Standard e-AT and 42 in Intensive e-AT completed the 12 Months Follow-up Survey. This is due to participant withdrawal and loss to follow-up.</population>
          <units>units (points) on a scale (from 1-5)</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="261"/>
                <count group_id="O2" value="57"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="261"/>
                    <count group_id="O2" value="57"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.63" lower_limit="4.49" upper_limit="4.77"/>
                    <measurement group_id="O2" value="4.63" lower_limit="4.49" upper_limit="4.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months Follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="166"/>
                    <count group_id="O2" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.38" lower_limit="4.23" upper_limit="4.53"/>
                    <measurement group_id="O2" value="4.54" lower_limit="4.35" upper_limit="4.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Child Interrupted/Missed School Days, Standard vs Intensive</title>
        <description>Number of child interrupted/missed school days were collected longitudinally at the same time as collecting the QOL scores: baseline, 3, 6, and 12 months in the study.
Number of child interrupted/missed school days during the 3 months prior to baseline, 3, 6, and 12 months follow-up surveys were counted.</description>
        <time_frame>Interrupted/missed school days were collected at baseline, 3, 6, and 12 month follow-ups</time_frame>
        <population>We had 261 Standard and 57 Intensive e-AT who completed baseline survey. Numbers in the row differ due to different number of participants who completed 3, 6, and 12 months surveys, due to participant compliance, withdrawal or loss-to-follow-up. 3, 6, and 12 month measurements were compared to Baseline, between Standard vs Intensive interventions</population>
        <group_list>
          <group group_id="O1">
            <title>Standard e-AT Intervention</title>
            <description>Patients in Standard e-AT intervention group will be using the standard version of e-AT.</description>
          </group>
          <group group_id="O2">
            <title>Intensive e-AT Intervention</title>
            <description>Participants in the intensive e-AT intervention group will be using an enhanced version of the standard e-AT, i.e. addition of progress bar indicating the patients' status of completing 4 scores in a month, fireworks when they reach 100% on the progress bar, a leaderboard to compare their own status among other e-AT users.</description>
          </group>
        </group_list>
        <measure>
          <title>Child Interrupted/Missed School Days, Standard vs Intensive</title>
          <description>Number of child interrupted/missed school days were collected longitudinally at the same time as collecting the QOL scores: baseline, 3, 6, and 12 months in the study.
Number of child interrupted/missed school days during the 3 months prior to baseline, 3, 6, and 12 months follow-up surveys were counted.</description>
          <population>We had 261 Standard and 57 Intensive e-AT who completed baseline survey. Numbers in the row differ due to different number of participants who completed 3, 6, and 12 months surveys, due to participant compliance, withdrawal or loss-to-follow-up. 3, 6, and 12 month measurements were compared to Baseline, between Standard vs Intensive interventions</population>
          <units>Number of interrupted/missed school days</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="261"/>
                <count group_id="O2" value="57"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="261"/>
                    <count group_id="O2" value="57"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="435"/>
                    <measurement group_id="O2" value="129"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Months Follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="178"/>
                    <count group_id="O2" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="114"/>
                    <measurement group_id="O2" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 Months Follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="182"/>
                    <count group_id="O2" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87"/>
                    <measurement group_id="O2" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 Months Follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="167"/>
                    <count group_id="O2" value="43"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="129"/>
                    <measurement group_id="O2" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Parent Interrupted/Missed Work Days, Standard vs Intensive</title>
        <description>Number of parent interrupted/missed work days were collected longitudinally at the same time as collecting the QOL scores: baseline, 3, 6, and 12 months in the study.
Number of parent interrupted/missed work days during the 3 months prior to baseline, 3, 6, and 12 months follow-up surveys were counted.</description>
        <time_frame>Interrupted/missed work days were measured baseline 3, 6, and 12 months</time_frame>
        <population>We had 261 Standard and 57 Intensive e-AT who completed baseline survey. Numbers in the row differ due to different number of participants who completed 3, 6, and 12 months surveys, due to participant compliance, withdrawal or loss-to-follow-up. 3, 6, and 12 month measurements were compared to Baseline, between Standard vs Intensive interventions</population>
        <group_list>
          <group group_id="O1">
            <title>Standard e-AT Intervention</title>
            <description>Patients in Standard e-AT intervention group will be using the standard version of e-AT.</description>
          </group>
          <group group_id="O2">
            <title>Intensive e-AT Intervention</title>
            <description>Participants in the intensive e-AT intervention group will be using an enhanced version of the standard e-AT, i.e. addition of progress bar indicating the patients' status of completing 4 scores in a month, fireworks when they reach 100% on the progress bar, a leaderboard to compare their own status among other e-AT users.</description>
          </group>
        </group_list>
        <measure>
          <title>Parent Interrupted/Missed Work Days, Standard vs Intensive</title>
          <description>Number of parent interrupted/missed work days were collected longitudinally at the same time as collecting the QOL scores: baseline, 3, 6, and 12 months in the study.
Number of parent interrupted/missed work days during the 3 months prior to baseline, 3, 6, and 12 months follow-up surveys were counted.</description>
          <population>We had 261 Standard and 57 Intensive e-AT who completed baseline survey. Numbers in the row differ due to different number of participants who completed 3, 6, and 12 months surveys, due to participant compliance, withdrawal or loss-to-follow-up. 3, 6, and 12 month measurements were compared to Baseline, between Standard vs Intensive interventions</population>
          <units>Number of interrupted/missed work days</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="261"/>
                <count group_id="O2" value="57"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="261"/>
                    <count group_id="O2" value="57"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="176"/>
                    <measurement group_id="O2" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Months Follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="178"/>
                    <count group_id="O2" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44"/>
                    <measurement group_id="O2" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 Months Follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="182"/>
                    <count group_id="O2" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42"/>
                    <measurement group_id="O2" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 Months Follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="167"/>
                    <count group_id="O2" value="43"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Asthma Control Change, Standard vs Intensive</title>
        <description>Asthma control information was collected weekly through the e-AT for 1 year. Asthma control was measured using the Asthma Control Test (ACT), which had a score ranging from 5 to 25, with 5 being poor control and 25 being optimal control. The analysis compared the mean change in scores from baseline to quarters 1, 2, 3, and 4.</description>
        <time_frame>Average baseline ACT scores compared to average ACT scores at quarter 1, 2, 3 and 4, and between Standard vs. Intensive</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard e-AT Intervention</title>
            <description>Patients in Standard e-AT intervention group using the standard version of e-AT.</description>
          </group>
          <group group_id="O2">
            <title>Intensive e-AT Intervention</title>
            <description>Participants in the intensive e-AT intervention group using an enhanced version of the standard e-AT, i.e. addition of progress bar indicating the patients' status of completing 4 scores in a month, fireworks when they reach 100% on the progress bar, a leaderboard to compare their own status among other e-AT users.</description>
          </group>
        </group_list>
        <measure>
          <title>Asthma Control Change, Standard vs Intensive</title>
          <description>Asthma control information was collected weekly through the e-AT for 1 year. Asthma control was measured using the Asthma Control Test (ACT), which had a score ranging from 5 to 25, with 5 being poor control and 25 being optimal control. The analysis compared the mean change in scores from baseline to quarters 1, 2, 3, and 4.</description>
          <units>mean score (points) change</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="261"/>
                <count group_id="O2" value="57"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Qtr 1 vs baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.55" spread="0.12"/>
                    <measurement group_id="O2" value="1.78" spread="0.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Qtr 2 vs baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.09" spread="0.10"/>
                    <measurement group_id="O2" value="2.18" spread="0.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Qtr 3 vs baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.26" spread="0.09"/>
                    <measurement group_id="O2" value="2.18" spread="0.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Qtr 4 vs baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.33" spread="0.10"/>
                    <measurement group_id="O2" value="3.30" spread="0.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Emergency Department (ED)/Hospitalization, Standard vs Intensive</title>
        <description>ED and hospital admissions were evaluated using data collected through Intermountain Healthcare claims data and ED visits and hospital encounters.
We evaluated number ED and hospital admissions 12 months prior to intervention and 12 months post intervention</description>
        <time_frame>Change in 1 year ED/hospital admission between 12-month prior and 12 month post e-AT use</time_frame>
        <population>Number of pre- and post e-AT ED and hospital admissions were compared between standard and intensive groups.</population>
        <group_list>
          <group group_id="O1">
            <title>Standard e-AT Intervention</title>
            <description>Patients in Standard e-AT intervention group will be using the standard version of e-AT.</description>
          </group>
          <group group_id="O2">
            <title>Intensive e-AT Intervention</title>
            <description>Participants in the intensive e-AT intervention group will be using an enhanced version of the standard e-AT, i.e. addition of progress bar indicating the patients' status of completing 4 scores in a month, fireworks when they reach 100% on the progress bar, a leaderboard to compare their own status among other e-AT users.</description>
          </group>
        </group_list>
        <measure>
          <title>Emergency Department (ED)/Hospitalization, Standard vs Intensive</title>
          <description>ED and hospital admissions were evaluated using data collected through Intermountain Healthcare claims data and ED visits and hospital encounters.
We evaluated number ED and hospital admissions 12 months prior to intervention and 12 months post intervention</description>
          <population>Number of pre- and post e-AT ED and hospital admissions were compared between standard and intensive groups.</population>
          <units>Number of ED/hospital admissions</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="261"/>
                <count group_id="O2" value="57"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Prior</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53"/>
                    <measurement group_id="O2" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Parent Satisfaction With Care, Overall (Change Overtime From Baseline to 12 Months)</title>
        <description>Parent satisfaction data was collected using a modified version of patient satisfaction survey developed and validated by Varni et al. at baseline and at 12 months in the study.
The scale ranged from 1-5, with 1=Very Dissatisfied and 5=Very Satisfied.</description>
        <time_frame>Satisfaction at 1 year following e-AT use was compared to baseline satisfaction scores</time_frame>
        <population>We had 318 participants who have completed the baseline satisfaction survey, and 208 who completed 12 months follow-up survey, due to participants withdrawing from the study and loss to follow-up.</population>
        <group_list>
          <group group_id="O1">
            <title>All e-AT Users</title>
            <description>This group consists of all e-AT users, both standard and intensive interventions.</description>
          </group>
        </group_list>
        <measure>
          <title>Parent Satisfaction With Care, Overall (Change Overtime From Baseline to 12 Months)</title>
          <description>Parent satisfaction data was collected using a modified version of patient satisfaction survey developed and validated by Varni et al. at baseline and at 12 months in the study.
The scale ranged from 1-5, with 1=Very Dissatisfied and 5=Very Satisfied.</description>
          <population>We had 318 participants who have completed the baseline satisfaction survey, and 208 who completed 12 months follow-up survey, due to participants withdrawing from the study and loss to follow-up.</population>
          <units>units (points) on a scale (from 1-5)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="318"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="318"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.66" spread="0.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 months Follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="208"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.46" spread="0.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Child Asthma Control Overall (Comparing Change of Asthma Control From Baseline to Quarter 1, Quarter 2, Quarter 3 and Quarter 4)</title>
        <description>Asthma control information was collected through the e-AT, comparing change of asthma control from baseline to quarter 1, quarter 2, quarter 3 and quarter 4.
Asthma control was measured using the Asthma Control Test (ACT), which scale ranged from 5-25, with 5=poorly controlled and 25=well controlled.
Each patient submitted an ACT score weekly for 12 months.</description>
        <time_frame>baseline ACT scores were compared to quarters 1, 2, 3, 4.</time_frame>
        <population>Patients were told to submit an ACT score once a week for 12 months. 311 patients completed at least one ACT score for a total number of 11418 ACT scores submitted using e-AT by all e-AT users (during study period).</population>
        <group_list>
          <group group_id="O1">
            <title>All e-AT Users</title>
            <description>This group consists of all e-AT users, both standard and intensive interventions. We will be looking at ACT scores submitted by the e-AT users to report asthma control over 12 months.</description>
          </group>
        </group_list>
        <measure>
          <title>Child Asthma Control Overall (Comparing Change of Asthma Control From Baseline to Quarter 1, Quarter 2, Quarter 3 and Quarter 4)</title>
          <description>Asthma control information was collected through the e-AT, comparing change of asthma control from baseline to quarter 1, quarter 2, quarter 3 and quarter 4.
Asthma control was measured using the Asthma Control Test (ACT), which scale ranged from 5-25, with 5=poorly controlled and 25=well controlled.
Each patient submitted an ACT score weekly for 12 months.</description>
          <population>Patients were told to submit an ACT score once a week for 12 months. 311 patients completed at least one ACT score for a total number of 11418 ACT scores submitted using e-AT by all e-AT users (during study period).</population>
          <units>Score (points) ranging from 5-25</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>ACT scores</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="311"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>ACT scores</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11418"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="311"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>ACT scores</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="311"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.85" spread="5.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Quarter 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="311"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>ACT scores</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2965"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.28" spread="3.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Quarter 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="311"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>ACT scores</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2861"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.82" spread="2.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Quarter 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="311"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>ACT scores</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2726"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.81" spread="2.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Quarter 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="311"/>
                  </count_list>
                </analyzed>
                <analyzed>
                  <units>ACT scores</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2555"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.97" spread="2.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Child Interrupted/Missed School Days, Overall (Longitudinal Changes Overtime)</title>
        <description>Number of child interrupted/missed school days were collected longitudinally (information includes mean at baseline, 3, 6, and 12 months in the study).</description>
        <time_frame>1 year</time_frame>
        <population>The numbers analyzed in the rows are different due to different number of participants completing the surveys throughout 3, 6, and 12 months. This was due to either compliance, withdrawal or loss to follow-up.</population>
        <group_list>
          <group group_id="O1">
            <title>All e-AT Users</title>
            <description>This group consists of all e-AT users, both standard and intensive interventions</description>
          </group>
        </group_list>
        <measure>
          <title>Child Interrupted/Missed School Days, Overall (Longitudinal Changes Overtime)</title>
          <description>Number of child interrupted/missed school days were collected longitudinally (information includes mean at baseline, 3, 6, and 12 months in the study).</description>
          <population>The numbers analyzed in the rows are different due to different number of participants completing the surveys throughout 3, 6, and 12 months. This was due to either compliance, withdrawal or loss to follow-up.</population>
          <units>Number of days (interrupted or missed)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="318"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="318"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.91" spread="5.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Months Follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.80" spread="2.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 Months Follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="224"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.52" spread="1.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 Months Follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="210"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.79" spread="2.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Parent Interrupted/Missed Work Days, Overall (Longitudinal Change Overtime)</title>
        <description>Number of parent interrupted/missed work days were collected longitudinally at the same time as collecting the QOL scores: Information includes mean at baseline, 3, 6, and 12 months in the study.</description>
        <time_frame>1 year</time_frame>
        <population>The numbers analyzed in the rows are different due to different number of participants completing the surveys throughout 3, 6, and 12 months. This was due to either compliance, withdrawal or loss to follow-up.</population>
        <group_list>
          <group group_id="O1">
            <title>All e-AT Users</title>
            <description>This group consists of all e-AT users, both standard and intensive interventions.</description>
          </group>
        </group_list>
        <measure>
          <title>Parent Interrupted/Missed Work Days, Overall (Longitudinal Change Overtime)</title>
          <description>Number of parent interrupted/missed work days were collected longitudinally at the same time as collecting the QOL scores: Information includes mean at baseline, 3, 6, and 12 months in the study.</description>
          <population>The numbers analyzed in the rows are different due to different number of participants completing the surveys throughout 3, 6, and 12 months. This was due to either compliance, withdrawal or loss to follow-up.</population>
          <units>Number of days (interrupted or missed)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="318"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="318"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.72" spread="1.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Months Follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.27" spread="0.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 Months Follow-Up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="224"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.25" spread="1.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 Months Follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="210"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.20" spread="0.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>ED/Hospital Admissions, e-AT Overall (Pre vs. Post e-AT Use Within Subjects That Received the e-AT Intervention)</title>
        <description>ED/hospital re-admission data were compared between prior and post 12 month period (for both intensive and standard interventions overall) when e-AT was administered.</description>
        <time_frame>1 year</time_frame>
        <population>Here we used intent-to-treat analysis and included the overall 325 (rather than 318 used in analysis of other outcomes) participants</population>
        <group_list>
          <group group_id="O1">
            <title>Prior e-AT Use</title>
            <description>The participants enrolled in both standard and intensive e-AT groups served as their own control. This arm includes ED/Hospital use among the participants 1 year before using the e-AT.</description>
          </group>
          <group group_id="O2">
            <title>Post e-AT Use</title>
            <description>The participants enrolled in both standard and intensive e-AT groups served as their own control. This arm includes ED/Hospital use among the participants 1 year after starting using the e-AT.</description>
          </group>
        </group_list>
        <measure>
          <title>ED/Hospital Admissions, e-AT Overall (Pre vs. Post e-AT Use Within Subjects That Received the e-AT Intervention)</title>
          <description>ED/hospital re-admission data were compared between prior and post 12 month period (for both intensive and standard interventions overall) when e-AT was administered.</description>
          <population>Here we used intent-to-treat analysis and included the overall 325 (rather than 318 used in analysis of other outcomes) participants</population>
          <units>number of ED/hospital admission</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="325"/>
                <count group_id="O2" value="325"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.22" spread="0.60"/>
                    <measurement group_id="O2" value="0.09" spread="0.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Use of Oral Steroid, Overall</title>
        <description>Use of oral steroid was evaluated using data collected through Intermountain Healthcare claims data and oral steroids prescribed. Comparison was made between prior and post e-AT (both interventions) overall.</description>
        <time_frame>1 year</time_frame>
        <population>Here we used intent-to-treat analysis and included the overall 325 (rather than 318 used in analysis of other outcomes) participants</population>
        <group_list>
          <group group_id="O1">
            <title>Prior e-AT Use</title>
            <description>The participants enrolled in both standard and intensive e-AT groups served as their own control. This arm includes oral steriod use among the participants 1 year before using the e-AT.</description>
          </group>
          <group group_id="O2">
            <title>Post e-AT Use</title>
            <description>The participants enrolled in both standard and intensive e-AT groups served as their own control. This arm includes the oral steriod use among the participants 1 year after starting using the e-AT.</description>
          </group>
        </group_list>
        <measure>
          <title>Use of Oral Steroid, Overall</title>
          <description>Use of oral steroid was evaluated using data collected through Intermountain Healthcare claims data and oral steroids prescribed. Comparison was made between prior and post e-AT (both interventions) overall.</description>
          <population>Here we used intent-to-treat analysis and included the overall 325 (rather than 318 used in analysis of other outcomes) participants</population>
          <units>number of oral steroid use</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="325"/>
                <count group_id="O2" value="325"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.74" spread="1.15"/>
                    <measurement group_id="O2" value="0.51" spread="0.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>ED/Hospital Admission, Early vs. Late Patients</title>
        <description>ED and hospital admission was evaluated using data collected through Intermountain Healthcare claims data and ED visits and hospital encounters. Analyses (at the patient level) comparing the rates of ED/hospital admissions between a 1 year period following initiation of the e-AT for those in both standard and intensive e-AT groups who were enrolled early during the study period (patients with enrollment dates between January 2014 and December 2014) to rates of ED/hospital admissions for patients who started the e-AT later (patients with enrollment dates between January 2015 and December 2015), during a 1-year period prior to the late patient starting the e-AT.</description>
        <time_frame>1 year following e-AT use for early and late starting patients</time_frame>
        <population>Intent-to-treat analysis was used, including all 325. Randomized comparisons compared intensive vs. standard e-AT, but not e-AT efficacy vs usual care. This nonrandomized analysis (Early vs Late Patients) assesses e-AT efficacy, comparing outcomes between ‚Äúperiod‚Äù patients were under the e-AT vs ‚Äúperiods‚Äù other patients were not using the e-AT.</population>
        <group_list>
          <group group_id="O1">
            <title>Early Starting Patients</title>
            <description>Patients starting with e-AT intervention early (in 2014)</description>
          </group>
          <group group_id="O2">
            <title>Late Starting Patients</title>
            <description>Patients starting with e-AT intervention later (in 2015)</description>
          </group>
        </group_list>
        <measure>
          <title>ED/Hospital Admission, Early vs. Late Patients</title>
          <description>ED and hospital admission was evaluated using data collected through Intermountain Healthcare claims data and ED visits and hospital encounters. Analyses (at the patient level) comparing the rates of ED/hospital admissions between a 1 year period following initiation of the e-AT for those in both standard and intensive e-AT groups who were enrolled early during the study period (patients with enrollment dates between January 2014 and December 2014) to rates of ED/hospital admissions for patients who started the e-AT later (patients with enrollment dates between January 2015 and December 2015), during a 1-year period prior to the late patient starting the e-AT.</description>
          <population>Intent-to-treat analysis was used, including all 325. Randomized comparisons compared intensive vs. standard e-AT, but not e-AT efficacy vs usual care. This nonrandomized analysis (Early vs Late Patients) assesses e-AT efficacy, comparing outcomes between ‚Äúperiod‚Äù patients were under the e-AT vs ‚Äúperiods‚Äù other patients were not using the e-AT.</population>
          <units>number of ED/Hospital admission</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="234"/>
                <count group_id="O2" value="91"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.10" spread="0.38"/>
                    <measurement group_id="O2" value="0.18" spread="0.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Oral Steroid Use, Early vs. Late Patients</title>
        <description>Oral steroid use data was collected through Intermountain Healthcare claims data and clinics prescribing oral steroid.
Oral steroid use was evaluated using data collected through Intermountain Healthcare claims data and oral steroids prescribed. Analyses (at the patient level) comparing the rates oral steroid use between a 1 year period following initiation of the e-AT for those in both standard and intensive e-AT groups who were enrolled early during the study period (patients with enrollment dates between January 2014 and December 2014) to rates of oral steroid use for patients who started the e-AT later (patients with enrollment dates between January 2015 and December 2015), during a 1-year period prior to the late patient starting the e-AT.</description>
        <time_frame>1 year</time_frame>
        <population>Intent-to-treat analysis was used, including all 325. Randomized comparisons compared intensive vs. standard e-AT, but not e-AT efficacy vs usual care. This nonrandomized analysis (Early vs Late Patients) assesses e-AT efficacy, comparing outcomes between ‚Äúperiod‚Äù patients were under the e-AT vs ‚Äúperiods‚Äù other patients were not using the e-AT.</population>
        <group_list>
          <group group_id="O1">
            <title>Early Starting Patients</title>
            <description>Patients starting with e-AT intervention early (in 2014)</description>
          </group>
          <group group_id="O2">
            <title>Late Starting Patients</title>
            <description>Patients starting with e-AT intervention later (in 2015)</description>
          </group>
        </group_list>
        <measure>
          <title>Oral Steroid Use, Early vs. Late Patients</title>
          <description>Oral steroid use data was collected through Intermountain Healthcare claims data and clinics prescribing oral steroid.
Oral steroid use was evaluated using data collected through Intermountain Healthcare claims data and oral steroids prescribed. Analyses (at the patient level) comparing the rates oral steroid use between a 1 year period following initiation of the e-AT for those in both standard and intensive e-AT groups who were enrolled early during the study period (patients with enrollment dates between January 2014 and December 2014) to rates of oral steroid use for patients who started the e-AT later (patients with enrollment dates between January 2015 and December 2015), during a 1-year period prior to the late patient starting the e-AT.</description>
          <population>Intent-to-treat analysis was used, including all 325. Randomized comparisons compared intensive vs. standard e-AT, but not e-AT efficacy vs usual care. This nonrandomized analysis (Early vs Late Patients) assesses e-AT efficacy, comparing outcomes between ‚Äúperiod‚Äù patients were under the e-AT vs ‚Äúperiods‚Äù other patients were not using the e-AT.</population>
          <units>number of oral steroid use</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="234"/>
                <count group_id="O2" value="91"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.53" spread="0.99"/>
                    <measurement group_id="O2" value="0.53" spread="0.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>ED/Hospital Admission, Early vs Late Starting Clinics (During the 3 Months When Late Starting Clinics Have Not Used the e-AT)</title>
        <description>ED and hospital admission evaluated using data collected through Intermountain Healthcare claims data and ED visits and hospital encounters. Statistical analysis was not conducted since the numbers of ED/Hospital admissions was very small (2 and 0) in both group (during the 3 months study window). Here we used intent-to-treat analysis and included the overall 325 (rather than 318 used in analysis of other outcomes) participants.</description>
        <time_frame>3-month period prior to the late clinics starting the e-AT</time_frame>
        <population>Intent-to-treat analysis was used, including all 325. Randomized comparisons compared intensive vs. standard e-AT, but not e-AT efficacy vs usual care. This nonrandomized analysis (Early vs Late Clinics) assesses e-AT efficacy, comparing outcomes between ‚Äúperiod‚Äù clinics were under the e-AT vs ‚Äúperiods‚Äù other clinics were not using the e-AT.</population>
        <group_list>
          <group group_id="O1">
            <title>Early Starting Clinics</title>
            <description>ED/Hospital admission for patients in clinics that started with the e-AT intervention from Jan 3, 2014 to Mar 24, 2014.</description>
          </group>
          <group group_id="O2">
            <title>Late Starting Clinics</title>
            <description>ED/Hospital admission for patients in clinics that started with the e-AT intervention after March 24, 2014.</description>
          </group>
        </group_list>
        <measure>
          <title>ED/Hospital Admission, Early vs Late Starting Clinics (During the 3 Months When Late Starting Clinics Have Not Used the e-AT)</title>
          <description>ED and hospital admission evaluated using data collected through Intermountain Healthcare claims data and ED visits and hospital encounters. Statistical analysis was not conducted since the numbers of ED/Hospital admissions was very small (2 and 0) in both group (during the 3 months study window). Here we used intent-to-treat analysis and included the overall 325 (rather than 318 used in analysis of other outcomes) participants.</description>
          <population>Intent-to-treat analysis was used, including all 325. Randomized comparisons compared intensive vs. standard e-AT, but not e-AT efficacy vs usual care. This nonrandomized analysis (Early vs Late Clinics) assesses e-AT efficacy, comparing outcomes between ‚Äúperiod‚Äù clinics were under the e-AT vs ‚Äúperiods‚Äù other clinics were not using the e-AT.</population>
          <units>number of ED/Hospital admission</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="206"/>
                <count group_id="O2" value="119"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Oral Steroid Use, Early vs Late Starting Clinics (During the 3 Months When Late Starting Clinics Have Not Started the e-AT)</title>
        <description>Use of oral steroid was evaluated using data collected through Intermountain Healthcare claims data and oral steroids prescribed. Statistical analysis was not conducted since the numbers of ED/Hospital admissions was very small (2 and 0) in both group (during the 3 months study window). Here we used intent-to-treat analysis and included the overall 325 (rather than 318 used in analysis of other outcomes) participants</description>
        <time_frame>3 month period prior to the late clinics starting the e-AT</time_frame>
        <population>Intent-to-treat analysis was used, including all 325. Randomized comparisons compared intensive vs. standard e-AT, but not e-AT efficacy vs usual care. This nonrandomized analysis (Early vs Late Clinics) assesses e-AT efficacy, comparing outcomes between ‚Äúperiod‚Äù clinics were under the e-AT vs ‚Äúperiods‚Äù other clinics were not using the e-AT.</population>
        <group_list>
          <group group_id="O1">
            <title>Early Patients</title>
            <description>Oral steroid use between Jan 3, 2014-March 24, 2014 for patients who were enrolled in e-AT intervention from Jan 3, 2014 to Mar 24, 2014.</description>
          </group>
          <group group_id="O2">
            <title>Late Patients</title>
            <description>Oral steroid use between Jan 3, 2014-March 24, 2014 for patients who were enrolled into e-AT after March 24, 2014.</description>
          </group>
        </group_list>
        <measure>
          <title>Oral Steroid Use, Early vs Late Starting Clinics (During the 3 Months When Late Starting Clinics Have Not Started the e-AT)</title>
          <description>Use of oral steroid was evaluated using data collected through Intermountain Healthcare claims data and oral steroids prescribed. Statistical analysis was not conducted since the numbers of ED/Hospital admissions was very small (2 and 0) in both group (during the 3 months study window). Here we used intent-to-treat analysis and included the overall 325 (rather than 318 used in analysis of other outcomes) participants</description>
          <population>Intent-to-treat analysis was used, including all 325. Randomized comparisons compared intensive vs. standard e-AT, but not e-AT efficacy vs usual care. This nonrandomized analysis (Early vs Late Clinics) assesses e-AT efficacy, comparing outcomes between ‚Äúperiod‚Äù clinics were under the e-AT vs ‚Äúperiods‚Äù other clinics were not using the e-AT.</population>
          <units>number of oral steroid use</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="206"/>
                <count group_id="O2" value="119"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>ED/Hospital Admissions, e-AT vs Usual Care</title>
        <description>Non randomized comparison of ED and hospital admissions between e-AT interventions (both intensive and standard) compared usual care (matched control patients drawn from non-participating clinics) in the prior vs. post e-AT intervention time periods.</description>
        <time_frame>1 year</time_frame>
        <population>Here we used intent-to-treat analysis and included the overall 325 (rather than 318 used in analysis of other outcomes) e-AT participants and 599 matched controls retrieved electronically from non-participating clinics.</population>
        <group_list>
          <group group_id="O1">
            <title>e-AT Intervention</title>
            <description>All e-AT users who have received the e-AT intervention for 12 months, randomized to either standard or intensive group.</description>
          </group>
          <group group_id="O2">
            <title>Usual Care (Non-randomized Cohort)</title>
            <description>Those who have not received any e-AT intervention and received usual care.</description>
          </group>
        </group_list>
        <measure>
          <title>ED/Hospital Admissions, e-AT vs Usual Care</title>
          <description>Non randomized comparison of ED and hospital admissions between e-AT interventions (both intensive and standard) compared usual care (matched control patients drawn from non-participating clinics) in the prior vs. post e-AT intervention time periods.</description>
          <population>Here we used intent-to-treat analysis and included the overall 325 (rather than 318 used in analysis of other outcomes) e-AT participants and 599 matched controls retrieved electronically from non-participating clinics.</population>
          <units>Rate per 1000-days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="325"/>
                <count group_id="O2" value="599"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Prior</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.59" spread="1.64"/>
                    <measurement group_id="O2" value="0.23" spread="1.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.24" spread="0.97"/>
                    <measurement group_id="O2" value="0.24" spread="0.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Oral Steroid Use, e-AT vs Usual Care</title>
        <description>Non randomized comparison of use of oral steroid between e-AT interventions (both intensive and standard) compared usual care (matched control patients drawn from non-participating clinics) in the prior vs. post e-AT intervention time periods.</description>
        <time_frame>1 year</time_frame>
        <population>Here we used intent-to-treat analysis and included the overall 325 (rather than 318 used in analysis of other outcomes) e-AT participants and 599 matched controls retrieved electronically from non-participating clinics.</population>
        <group_list>
          <group group_id="O1">
            <title>e-AT Intervention</title>
            <description>All e-AT users who have received the e-AT intervention for 12 months, randomized to either standard or intensive group.</description>
          </group>
          <group group_id="O2">
            <title>Usual Care (Non-randomized Cohort)</title>
            <description>Matched control participants from non-participating clinics that have not received any e-AT intervention and received usual care.</description>
          </group>
        </group_list>
        <measure>
          <title>Oral Steroid Use, e-AT vs Usual Care</title>
          <description>Non randomized comparison of use of oral steroid between e-AT interventions (both intensive and standard) compared usual care (matched control patients drawn from non-participating clinics) in the prior vs. post e-AT intervention time periods.</description>
          <population>Here we used intent-to-treat analysis and included the overall 325 (rather than 318 used in analysis of other outcomes) e-AT participants and 599 matched controls retrieved electronically from non-participating clinics.</population>
          <units>Rate per 1000-days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="325"/>
                <count group_id="O2" value="599"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Prior</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.02" spread="3.14"/>
                    <measurement group_id="O2" value="1.87" spread="3.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.41" spread="2.60"/>
                    <measurement group_id="O2" value="1.99" spread="7.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>This study is a minimal risk study, with patients logging in to a secure web-based self-management tool and answering questions about their asthma symptoms. The only intervention in the study was to have patients use this tool to manage asthma. No serious adverse risk is involved in this study.</desc>
      <group_list>
        <group group_id="E1">
          <title>Standard e-AT Intervention</title>
          <description>Patients in Standard e-AT intervention group will be using the standard version of e-AT.</description>
        </group>
        <group group_id="E2">
          <title>Intensive e-AT Intervention</title>
          <description>Participants in the intensive e-AT intervention group will be using an enhanced version of the standard e-AT, i.e. addition of progress bar indicating the patients' status of completing 4 scores in a month, fireworks when they reach 100% on the progress bar, a leaderboard to compare their own status among other e-AT users.</description>
        </group>
        <group group_id="E3">
          <title>Usual Care (Non-Randomized Cohort)</title>
          <description>Both arms (Intensive and standard e-AT interventions) will be compared to each other as well as to a non-randomized cohort who did not receive the e-AT interventions. These non-randomized cohort will be matched 2:1 to each randomized individuals.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="599"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="599"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Flory Nkoy</name_or_title>
      <organization>University of Utah</organization>
      <phone>801-662-3660</phone>
      <email>flory.nkoy@hsc.utah.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

